Systematic review: Is the use of NSAIDs safe during pregnancy in women with rheumatic disease?;Revisión sistemática: ¿Es seguro el uso de AINE durante el embarazo en mujeres con afección reumática?

Reumatologia Clinica

Volumn 4, Issue 5, 2008, Pages 191-196

  Martínez López, Juan Antonio ^a  

^a UNIDAD DE INVESTIGACIÓN   (Spain)

Author keywords

Congenital malformation; Non steroidal anti inflammatory drugs; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID;

ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DRUG SAFETY; GESTATIONAL AGE; HUMAN; LABOR; LIP MALFORMATION; LIVE BIRTH; OSTEOARTHRITIS; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY OUTCOME; PSORIATIC ARTHRITIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; STILLBIRTH; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; UNSPECIFIED SIDE EFFECT;

EID: 54549112237     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/S1699-258X(08)72463-X     Document Type: Article

References (19)

1. Brooks PM, Needs CJ. Antirheumatic drugs in pregnancy and lactation. Bailliere's Clinical Rheumatology. 1990;4:157-71.
2. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6.a ed. Philadelphia: Lippincott Williams and Wilkins; 2002.
3. Vermillion ST, Scardo JA, Lashus AG, Wiles HB. The effect of indomethacin toxolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol. 1997;177:256-9.
4. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum. 2005;35:112-21.
5. Østensen M, Motta M. Therapy insight: The use of antirheumatic drugs during nursing. Nat Clin Pract Rheumatol. 2007;3:400-6.
6. Oxford Centre for Evidence-based Medicine Levels of Evidence (May 2001) [citado 14 Abr 2008]. Disponible en: http://www.cebm.net/index.aspx?o=1025
7. Lewis RB, Schulman JD. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet. 1973;2:1159-61.
8. Østensen M, Østensen H. Safety of nonsteroidal anti-inflammatory drugs in pregnant patients with rheumatic disease. J Rheumatol. 1996;23:1045-9.
9. Ericson A, Kallen BA. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol. 2001;15:371-5.
10. Warkany J, Takacs E. Experimental production of congenital malformations in rats by salicylate poisoning. Am J Pathol. 1959;35:315.
11. Transler DG. Aspirin-induced cleft lip and other malformations in mice. Lancet. 1965;1:606.
12. Palmer AK. Sporadic malformation in laboratory animals. Adv Exp Med Biol. 1972;27:48.
13. Østensen M, Ramsay-Goldman R. Treatments of inflammatory rheumatic disorders in pregnancy. Drug Safety. 1998;19:389-410.
14. Brooks PM, Needs CJ. The use of antirheumatic medication during pregnancy and in the puerperium. Rheum Dis Clin North Am. 1989;15:789-806.
15. Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol. 2002;187:1623-30.
16. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003;327:368.
17. Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001;322:266-70.
18. Correy JF, Newman NM, Collins JA, Burrows EA, Burrows RF, Curran JT. Use of prescription drugs in the first trimester and congenital malformations. Aust N Z J Obstet Gynaecol. 1991;31:340.
19. Pons JC, Nekhlyudov L, Delfraissy JF. The course of the SAPHO syndrome during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;70:215-6.